Provider: Wright Reports
Tecan Group AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Tecan Group AG Adjusts FY 2013 Revenue Guidance
Tecan Group AG announced that based on stable sales for the Group in the first half of 2013 and a lower than anticipated order entry in the Life Science Business to date, the Company now expects moderate growth in local currency terms for fiscal 2013. Previously, Tecan was targeting sales growth to be in the mid-single-digit percentage range for fiscal 2013. The Company reported revenue of CHF391.11 million in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of CHF407.61 million in fiscal 2013.
Latest Developments for Tecan Group AG
- Tecan Group AG acquires IBL International to offer integrated solution for specialty diagnostics
- Tecan Group AG gives FY 2014 revenue guidance; to propose final dividend
- Tecan Group AG Comments on Revenue Growth Guidance by FY 2015; Proposes Dividend for FY 2012
- Tecan Group AG Reaffirms FY 2012 Revenue Guidance-Conference Call
- Share this
- Digg this